Sensitivity | Specificity | PPV | NPV | AUC | |
---|---|---|---|---|---|
Cardiac morphology | |||||
RVEDV index ≥ 75 ml/m2 | 67 | 50 | 89 | 20 | 0.72* |
RV mass index ≥ 20 g/m2 | 83 | 84 | 96 | 50 | 0.91* |
VMI ≥ 0.4 | 81 | 88 | 97 | 50 | 0.91* |
Late gadolinium enhancement | 83 | 94 | 98 | 58 | 0.89* |
Right heart functional indices | |||||
RVEF ≤ 35% | 67 | 71 | 93 | 28 | 0.72* |
RVSVI ≤ 30 ml/m2 | 70 | 47 | 89 | 21 | 0.68* |
TAPSE ≤ 2 cm | 76 | 64 | 92 | 32 | 0.75* |
f-TAAD ≤ 25% | 88 | 56 | 92 | 44 | 0.78* |
SFD ≤ 1 cm | 77 | 67 | 93 | 34 | 0.73* |
f-SFD ≤ 25% | 79 | 64 | 92 | 35 | 0.78* |
RVRAC ≤ 30% | 61 | 81 | 95 | 28 | 0.79* |
sEI ≥ 1.2 | 65 | 61 | 90 | 24 | 0.72* |
dEI ≥ 1.17 | 62 | 54 | 88 | 20 | 0.57 |
Phase contrast CMR | |||||
Average velocity ≤ 10 (cm/s) | 82 | 62 | 94 | 32 | 0.80* |
Retrograde flow ≥ 0.3 (L/min/m2) | 83 | 71 | 95 | 38 | 0.84* |
Retrograde flow (%) | 73 | 56 | 87 | 34 | 0.75* |
PA relative area change ≥ 15% | 86 | 70 | 94 | 48 | 0.87* |
Systolic PA area ≥ 8 cm2 | 74 | 67 | 92 | 32 | 0.77* |
Diastolic PA area ≥ 6 cm2 | 88 | 66 | 94 | 52 | 0.82* |